(Date:9/4/2008)...een Syracuse University and the Serum Institute of...vaccines for children living in some of the most i...ently awarded $250,000 to a team of SU researchers...stry in the College of Arts and Sciences, to devel..., a severe form of diarrhea that affects infants a...
(Date:9/4/2008)...d a gene enhancer, known as HACNS1, that may have ...able human thumb, and possibly also modifications ...two legs, according to a paper published in Scien...to provide evidence of the existence of human-spec... in the human genome. , Dr. Shyam Prabhakar, f...
(Date:9/4/2008)...evelopment of powerful supercomputers capable of a...rk a technological milestone capable of bringing c...ring, and business worldwide. Researchers at the U...nd Atmospheric Science, collaborating with NCAR (N...nter for Ocean-Land-Atmospheric Studies) and the U...
(Date:9/4/2008)...ailable in German . , Cystic kidney disease, re...es of the excretory organs are characterized by ov...cteristic proteins in the renal cells. An internat...ists from DKFZ and Heidelberg University Hospitals...tigate these conditions. , The researchers intr...
Breaking Biology News(10 mins):Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Petascale climate modeling heats up at University of Miami 2Petascale climate modeling heats up at University of Miami 3Gaining a better understanding of kidney diseases 2ThalesNano Inc and sanofi aventis R 26D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time 5582 1ThalesNano Inc and sanofi aventis R 26D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time 5582 2Nyer Medical Group Inc Reports Revenues of 2418 9 Million With Net Loss of 24 16 Per Share for 3rd Quarter of Fiscal Year 2008 20049 1Nyer Medical Group Inc Reports Revenues of 2418 9 Million With Net Loss of 24 16 Per Share for 3rd Quarter of Fiscal Year 2008 20049 2Nyer Medical Group Inc Reports Revenues of 2418 9 Million With Net Loss of 24 16 Per Share for 3rd Quarter of Fiscal Year 2008 20049 3Drive Through Mastectomies Threaten Patients Lives 20044 1Drive Through Mastectomies Threaten Patients Lives 20044 2BioMarin to Host Research and Development Day June 5th 5577 1BioMarin to Host Research and Development Day June 5th 5577 2...tists have found early indicators of inflammation ... caused by repetitive motion. , Their findings co... of debilitating conditions such as carpal tunnel ...emple University senior researchers Ann Barr and M..., in the March issue of Clinical Science, found th...
...ly and are generally discovered when the memory ha...m Karolinska Institutet shows, however, that appro...efore the symptoms manifest themselves. , Dementi...ion caused by some kind of dementia disease of the...lthough there is currently no cure for Alzheimer,s...
...ty shows that selfless and social behavior is not ...gious environment. After studying the behavior of ...tic behavior and religiousness tended to appear to...tal and genetic factors. , According to study auth...ndividuals are more social and giving because of t...
...laboration with colleagues from UC Berkeley and St...has designed a novel pulsed microjet system engine...t the pain or bruising that deeper penetration inj...nline today in the Proceedings of the National Aca...ree drug delivery systems is driven by a combinati...
Other Biology News:Red flag for repetitive stress injuries identified for first time in humans 2Gene tests and brain imaging reveal early dementia 2Researchers design pulsed mircrojet system to deliver protein drugs without pain or bruising 2(Date:9/4/2008)... - Revenues of $88.4 million, up 14% from the, pr...0.28, an increase of, 47% over last year,s third ...r-to-date operating cash flow of $62 million) - Ra...and earnings guidance, COLUMBIA, Md., Sept. 4 /PR...ion (Nasdaq: MATK ) today announced its financial...
(Date:9/4/2008)... The University of North Carolina-Chapel Hill ... Sciences, RESEARCH TRIANGLE PARK, N.C., Sept. 4 ...ciences and the University of North Carolina at,Ch...Center for Drug Safety,Sciences that will be led b...erts in drug-induced liver injury. As founding dir...
(Date:9/4/2008).../Xinhua-- Genesis,Pharmaceu...) ("Genesis" or,the "Company"), a leading pharmace...today announced that it completed a 40-for-1 rever...n trading under the symbol "GNPH.", Upon today,s ...trade,under the symbol "GTEC" and will begin tradi...
(Date:9/4/2008)...ymbol: MS, EDMONTON, Sept. 4 /PRNewswire-FirstCal...loper in the treatment of multiple sclerosis (MS),...tion (FDA) of the United States,has granted fast t...cotide,(MBP8298), for the treatment of secondary p...ently being evaluated in a U.S. pivotal phase III ...
Breaking Biology Technology:Martek Announces Third Quarter 2008 Financial Results 2Martek Announces Third Quarter 2008 Financial Results 3Martek Announces Third Quarter 2008 Financial Results 4Martek Announces Third Quarter 2008 Financial Results 5Martek Announces Third Quarter 2008 Financial Results 6Martek Announces Third Quarter 2008 Financial Results 7Martek Announces Third Quarter 2008 Financial Results 8Martek Announces Third Quarter 2008 Financial Results 9Martek Announces Third Quarter 2008 Financial Results 10New Hamner-UNC Center for Drug Safety Sciences 2New Hamner-UNC Center for Drug Safety Sciences 3Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 2Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol 3BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 2BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 3BioMS Medical's lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA 4...ce Foundation has awarded $1.6 million in federal ... department for work on better data encryption and...etworks. , ,The three-year grant is for research o... privacy. The Division of Public Health in Wiscons...the Public Health Information Network system built...
...ummer slowing the flow of news in the technology b...de significant product announcements. , ,Macromedi... 8, its development suite for web developers and d...oint products including Dreamweaver, Flash Profess...he release of Studio 8 offers several improvements...
...and its Fiserv EFT business unit on Wednesday anno...ansaction volume and strong growth rates in key tr...005. , ,Fiserv EFT is an ATM and point-of-sale (PO...ed volume of 2.28 billion transactions, a 13% incr... , ,The Fiserv-owned ACCEL/Exchange Network, the n...
...e are expected to gather here in November for a fi...e nation,s food supply. , ,The gathering, Great L...d private sector representatives from regional sta...cker, who, with the Wisconsin Procurement Institut...n nothing else like this in the country," said Due...
Other Biology Technology:UW-Madison gets $1.6 million to develop medical privacy safeguards 2Hot products launch in summer's slow days 2Hot products launch in summer's slow days 3Milwaukee to host inaugural Great Lakes Agro-Security Symposium 2Milwaukee to host inaugural Great Lakes Agro-Security Symposium 3... creates isogenic cell lines all transfected clone...rest. This homogeneous expression is demonstrated ... the coding sequence for chloramphenicol-acetyl tr...transfected into Flp-In-293 cells. Western blot an...
Growth Medium / Media
csiRNA By Request,1500 RNAi Reactions from Panomics
Recombinant Rat Leptin, CF
Biology Products: